GGrantIndex
← Leaderboards

Dimitri Krainc

Massachusetts General Hospital

$24,610,296
Attributed
$28,113,773
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,113,773 · 14

By mechanism

R01$15,843,901 · 7
R35$5,598,826 · 1
R37$3,147,792 · 1
U01$1,445,403 · 1
P01$1,045,169 · 1
K08$682,609 · 1

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Parkinson Disease

Research focus

Parkinson DiseaseNeuronsCellsPathway InteractionsMediatingNeurodegenerative DisordersMutationNerve DegenerationProteinsFunctional DisorderPathogenesisLinkMutantInduced Pluripotent Stem CellInsightBrainTherapeutic TargetIn VivoMouse ModelGenesLoss Of FunctionPhenotypeLeadMitochondria

Grant awards (69)

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease$1,200,000
R35 · FY2025 · NS · contact PI
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease$1,164,000
R35 · FY2024 · NS · contact PI
Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics$453,492
R01 · FY2024 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease$1,200,000
R35 · FY2023 · NS · contact PI
Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics$467,518
R01 · FY2023 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease$1,200,000
R35 · FY2022 · NS · contact PI
Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics$467,518
R01 · FY2022 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease$834,826
R35 · FY2021 · NS · contact PI
Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics$467,518
R01 · FY2021 · NS
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein$645,210
R37 · FY2020 · NS · contact PI
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease$566,475
R01 · FY2020 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$559,235
R01 · FY2020 · NS · contact PI
Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics$499,301
R01 · FY2020 · NS
Functional investigation of the role of TYR mutations and neuromelanin in Parkinson's disease$237,000
R21 · FY2020 · AG · contact PI
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease$578,201
R01 · FY2019 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$574,087
R01 · FY2019 · NS · contact PI
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein$571,581
R37 · FY2019 · NS · contact PI
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein$631,078
R37 · FY2018 · NS · contact PI
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease$590,055
R01 · FY2018 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$587,833
R01 · FY2018 · NS · contact PI
Mitochondrial and DA determinants of human SN DA neuron vulnerability in PD$113,073
P50 · FY2018 · NS · contact PI
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein$632,142
R37 · FY2017 · NS · contact PI
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease$600,253
R01 · FY2017 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$595,261
R01 · FY2017 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$374,425
U01 · FY2017 · NS
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein$667,781
R37 · FY2016 · NS · contact PI
Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease$634,221
R01 · FY2016 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$418,873
U01 · FY2016 · NS
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$558,458
U01 · FY2015 · NS
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$337,969
R01 · FY2015 · NS · contact PI
The role of Sirt1 in Huntington's Disease.$337,969
R01 · FY2015 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$93,647
U01 · FY2015 · NS
The role of Sirt1 in Huntington's Disease.$334,590
R01 · FY2014 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$334,590
R01 · FY2014 · NS · contact PI
Protein Acetylation and Selective Autophagy$327,897
R01 · FY2014 · NS · contact PI
The role of Sirt1 in Huntington's Disease.$261,627
R01 · FY2013 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$235,453
R01 · FY2013 · NS · contact PI
Protein Acetylation and Selective Autophagy$220,479
R01 · FY2013 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$138,183
R01 · FY2013 · NS · contact PI
Protein Acetylation and Selective Autophagy$101,083
R01 · FY2013 · NS · contact PI
The role of Sirt1 in Huntington's Disease.$93,179
R01 · FY2013 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$387,188
R01 · FY2012 · NS · contact PI
The role of Sirt1 in Huntington's Disease.$368,179
R01 · FY2012 · NS · contact PI
Protein Acetylation and Selective Autophagy$333,225
R01 · FY2012 · NS · contact PI
The Role of Lysosomal Glucocerebrosidase in Synucleinopathies$387,188
R01 · FY2011 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$346,920
R01 · FY2011 · NS · contact PI
Protein Acetylation and Selective Autophagy$333,225
R01 · FY2011 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$350,460
R01 · FY2010 · NS · contact PI
Protein Acetylation and Selective Autophagy$340,025
R01 · FY2010 · NS · contact PI
Protein Acetylation and Selective Autophagy$81,869
R01 · FY2010 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$50,000
R01 · FY2010 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$332,833
R01 · FY2009 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$318,525
R01 · FY2009 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$88,375
R01 · FY2009 · NS · contact PI
Transcriptional Regulation of PGC-1 in Huntington's Disease$351,333
R01 · FY2008 · NS · contact PI
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN HUNTINGTON'S DISEASE$345,345
R01 · FY2008 · NS · contact PI
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN HUNTINGTON'S DISEASE$345,345
R01 · FY2007 · NS · contact PI
Regulation of Sp1-mediated gene transcription in Huntington's Disease$200,908
P01 · FY2007 · NS · contact PI
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN HUNTINGTON'S$355,660
R01 · FY2006 · NS · contact PI
Regulation of Sp1-mediated gene transcription in HD$210,572
P01 · FY2006 · NS · contact PI
MECHANISMS OF TRANSCRIPTIONAL REPRESSION IN HUNTINGTON'S$364,219
R01 · FY2005 · NS
Regulation of Sp1-mediated gene transcription in HD$208,189
P01 · FY2005 · NS
Regulation of Sp1-mediated gene transcription in HD$208,044
P01 · FY2004 · NS
EFFECTS OF HUNTINGTON ON GENE TRANSCRIPTION$170,678
K08 · FY2004 · NS
Regulation of Sp1-mediated gene transcription in HD$217,456
P01 · FY2003 · NS
EFFECTS OF HUNTINGTON ON GENE TRANSCRIPTION$170,678
K08 · FY2003 · NS
EFFECTS OF HUNTINGTON ON GENE TRANSCRIPTION$113,751
K08 · FY2002 · NS
EFFECTS OF HUNTINGTON ON GENE TRANSCRIPTION$113,751
K08 · FY2001 · NS
EFFECTS OF HUNTINGTON ON GENE TRANSCRIPTION$113,751
K08 · FY2000 · NS